Werner syndrome protein 1367 variants and disposition towards coronary artery disease in Caucasian patients

被引:23
作者
Bohr, VA
Metter, EJ
Harrigan, JA
von Kobbe, C
Liu, JL
Gray, MD
Majumdar, A
Wilson, DA
Seidman, MM
机构
[1] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA
[2] NIA, Clin Resource Branch, NIH, Baltimore, MD 21224 USA
[3] MDG Associates, Seattle, WA 98126 USA
关键词
Werner syndrome; helicase; nuclease; genetic polymorphism; coronary artery disease;
D O I
10.1016/j.mad.2004.05.001
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The leading causes of death for individuals with Werner syndrome (WS) are myocardial infarction (MI) and stroke. The WS gene encodes a nuclear protein with both helicase and exonuclease activities. While individuals with WS have mutations that result in truncated, inactive proteins, several sequence variants have been described in apparently unaffected individuals. Some of these gene polymorphisms encode non-conservative amino acid substitutions, and it is expected that the changes would affect enzyme activity, although this has not been determined. Two research groups have studied the Cys/Arg 1367 polymorphism (located near the nuclear localization signal) in healthy and MI patients. Their results suggest that the Arg allele is protective against MI. We have characterized the Cys (C) and Arg (R) forms of the protein and find no notable difference in helicase and nuclease activities, or in nuclear/cytoplasmic distribution. The frequency of the C/R alleles in healthy individuals and subjects with coronary artery disease (CAD) drawn from the Baltimore Longitudinal Study of Aging (BLSA) was also examined. There was no indication that the R allele was protective against CAD. We conclude that the C/R polymorphism does not affect enzyme function or localization and does not influence CAD incidence in the BLSA cohort. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:491 / 496
页数:6
相关论文
共 25 条
[1]   Pathways defective in the human premature aging disease Werner syndrome [J].
Bohr, VA ;
Brosh, RM ;
von Kobbe, C ;
Opresko, P ;
Karmakar, P .
BIOGERONTOLOGY, 2002, 3 (1-2) :89-94
[2]  
Castro E, 1999, AM J MED GENET, V82, P399, DOI 10.1002/(SICI)1096-8628(19990219)82:5<399::AID-AJMG8>3.0.CO
[3]  
2-R
[4]  
Castro E, 2000, AM J MED GENET, V95, P374, DOI 10.1002/1096-8628(20001211)95:4<374::AID-AJMG14>3.0.CO
[5]  
2-4
[6]  
Chen Lishan, 2002, Journal of Biomedicine & Biotechnology, V2, P46, DOI 10.1155/S1110724302201011
[7]   POWER AND SAMPLE-SIZE CALCULATIONS - A REVIEW AND COMPUTER-PROGRAM [J].
DUPONT, WD ;
PLUMMER, WD .
CONTROLLED CLINICAL TRIALS, 1990, 11 (02) :116-128
[8]   WERNERS SYNDROME - A REVIEW OF ITS SYMPTOMATOLOGY NATURAL HISTORY PATHOLOGIC FEATURES GENETICS AND RELATIONSHIP TO NATURAL AGING PROCESS [J].
EPSTEIN, CJ ;
MARTIN, GM ;
SCHULTZ, AL ;
MOTULSKY, AG .
MEDICINE, 1966, 45 (03) :177-+
[9]   The Werner syndrome protein is a DNA helicase [J].
Gray, MD ;
Shen, JC ;
KamathLoeb, AS ;
Blank, A ;
Sopher, BL ;
Martin, GM ;
Oshima, J ;
Loeb, LA .
NATURE GENETICS, 1997, 17 (01) :100-103
[10]   The Werner syndrome protein stimulates DNA polymerase β strand displacement synthesis via its helicase activity [J].
Harrigan, JA ;
Opresko, PL ;
von Kobbe, C ;
Kedar, PS ;
Prasad, R ;
Wilson, SH ;
Bohr, VA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (25) :22686-22695